(Q36904866)

17 August 2017

1 reference

title

Assigning new roles to topical tacrolimus (English)

1 reference

17 August 2017

Stamatis Gregoriou

3

1 reference

ORCID Public Data File 2021

author name string

Eustathios Rallis

series ordinal

1

1 reference

17 August 2017

Chrysovalantis Korfitis

series ordinal

2

1 reference

17 August 2017

Dimitris Rigopoulos

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Expert Opinion on Investigational Drugs

17 August 2017

published in

1 reference

17 August 2017

volume

16

1 reference

17 August 2017

issue

8

1 reference

17 August 2017

page(s)

1267-1276

1 reference

Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

An open‐label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Treatment of chronic actinic dermatitis with tacrolimus ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Nodular prurigo responding to topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Successful treatment of stasis dermatitis with topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Tacrolimus ointment improves psoriasis in a microplaque assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Tacrolimus ointment is effective for facial and intertriginous psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus in the treatment of inverse psoriasis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Minoxidil vs finasteride in the treatment of men with androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Facial lichen striatus: successful treatment with tacrolimus ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus therapy for localized bullous pemphigoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical Tacrolimus Ointment Is an Effective Therapy for Hailey-Hailey Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus (FK506): treatment failure in four cases of alopecia universalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus in alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Erosive pustular dermatosis of the scalp: treatment with topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Tacrolimus effect on rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Childhood granulomatous periorificial dermatitis: lupus miliaris disseminatus faciei in children?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Cutaneous sarcoidosis successfully treated with topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Successful treatment of disseminated granuloma annulare with topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus in granuloma annulare and necrobiosis lipoidica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Annular atrophic plaques on the arms of a 57-year-old woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus in the management of peristomal pyoderma gangrenosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Combination therapy of doxycycline and topical tacrolimus for venous ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Localized scleroderma: response to occlusive treatment with tacrolimus ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus in the treatment of annular erythema associated with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus in the treatment of bovine collagen hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Successful treatment of pityriasis lichenoides with topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus: an effective therapy for Zoon balanitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Lichen amyloidosis improved by 0.1% topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Successful treatment of eosinophilic pustular folliculitis with topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

A case of Darier's disease successfully treated with topical tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical calcineurin inhibitors in treating Jessner's lymphocytic infiltration of the skin: report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Treatment of facial lesion of cutaneous plasmacytosis with tacrolimus ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

A case of reticular erythematous mucinosis treated with topical tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Treatment of pyostomatitis vegetans with topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Exfoliative cheilitis successfully treated with topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

A case of angiolymphoid hyperplasia with eosinophilia successfully treated with tacrolimus ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Familial Lassueur-Graham-Little-Piccardi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical treatment of Netherton's syndrome with tacrolimus ointment without significant systemic absorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

0.1% tacrolimus ointment for the treatment of intertrigo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Successful treatment of pruritus with topical tacrolimus in a patient with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Allergic contact dermatitis from tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Herpes simplex of the vulva evoked by topical tacrolimus treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

The "black box" warning and allergy drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

Tacrolimus: focusing on atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1267

10.1517/13543784.16.8.1267

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference